药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Enprofylline
Diphenadione
The risk or severity of bleeding can be increased when Diphenadione is combined with Mitoxantrone.
Enprofylline
Ethyl biscoumacetate
The risk or severity of bleeding can be increased when Ethyl biscoumacetate is combined with Mitoxantrone.
Enprofylline
Rivaroxaban
The risk or severity of bleeding can be increased when Rivaroxaban is combined with Mitoxantrone.
Enprofylline
Betrixaban
The risk or severity of bleeding can be increased when Betrixaban is combined with Mitoxantrone.
Enprofylline
Edoxaban
The risk or severity of bleeding can be increased when Edoxaban is combined with Mitoxantrone.
Enprofylline
Dabigatran etexilate
The risk or severity of bleeding can be increased when Dabigatran etexilate is combined with Mitoxantrone.
Enprofylline
Apixaban
The risk or severity of bleeding can be increased when Apixaban is combined with Mitoxantrone.
Enprofylline
Dabigatran
The risk or severity of bleeding can be increased when Dabigatran is combined with Mitoxantrone.
Enprofylline
Edetate calcium disodium anhydrous
The risk or severity of bleeding can be increased when Edetate calcium disodium anhydrous is combined with Mitoxantrone.
Enprofylline
Tocopherylquinone
The risk or severity of bleeding can be increased when Tocopherylquinone is combined with Mitoxantrone.
Enprofylline
Saruplase
The risk or severity of bleeding can be increased when Saruplase is combined with Mitoxantrone.
Enprofylline
Melagatran
The risk or severity of bleeding can be increased when Melagatran is combined with Mitoxantrone.
Enprofylline
Tioclomarol
The risk or severity of bleeding can be increased when Tioclomarol is combined with Mitoxantrone.
Enprofylline
Brinase
The risk or severity of bleeding can be increased when Brinase is combined with Mitoxantrone.
Enprofylline
Protein S human
The risk or severity of bleeding can be increased when Protein S human is combined with Mitoxantrone.
Enprofylline
Gabexate
The risk or severity of bleeding can be increased when Gabexate is combined with Mitoxantrone.
Enprofylline
Monteplase
The risk or severity of bleeding can be increased when Monteplase is combined with Mitoxantrone.
Enprofylline
Nafamostat
The risk or severity of bleeding can be increased when Nafamostat is combined with Mitoxantrone.
Enprofylline
Darexaban
The risk or severity of bleeding can be increased when Darexaban is combined with Mitoxantrone.
Enprofylline
Letaxaban
The risk or severity of bleeding can be increased when Letaxaban is combined with Mitoxantrone.